ΒιΆΉ΄«Γ½

Meeting Coverage

IDWeek Video Pearls

Video Pearls from the Joint Meeting of IDSA, SHEA, HIVMA, and PIDS

Novel Weekly Oral HIV Drug Safe in Early Trial of Healthy Volunteers

In a phase Ia trial, long-acting integrase inhibitor was associated with very few adverse events

image

Latest IDWeek Video Pearls Meeting Coverage

Real-World Use of Long-Acting Cabotegravir for PrEP

High adherence, persistence, and safety shown in diverse populations over first 2 years

November 6, 2024
RSV Vaccine 90% Effective in High-Risk Adults, Real-World Study Shows

Vaccination tied to fewer hospitalizations and emergency department visits

October 30, 2024
Nationwide Initiative Cuts Down Inappropriate Antibiotic Prescribing

AHRQ was designed to build antibiotic stewardship as an important approach to patient safety

November 9, 2021
Remdesivir Averts Hospitalization in High-Risk COVID Patients

Joshua Hill, MD, says the antiviral treatment "provides another tool in our tool belt"

November 2, 2021
Premature Mortality Highest Among Black Women With HIV

Jessica Castilho, MD, MPH, hopes we can work toward figuring out why

October 26, 2021
Reduced COVID Vaccine Response in People With HIV

Matthew Spinelli, MD, says patients with lower CD4 counts should be prioritized for boosters

October 19, 2021
Switching Tenofovir HIV Regimens Can Cause Weight Gain

Research suggests that TDF actually suppresses body weight

December 30, 2020
Acute HIV Infections Increased During COVID-19

Routine tests for HIV went down during the pandemic

December 10, 2020
Acute HIV Cases Have Doubled During COVID-19

Matthew Spinelli, MD, is worried "this could be an omen of what we could see in the next year"

November 12, 2020
Antibiotics as STD Prophylaxis in Addition to PrEP?

Doug Krakower debates with Annie Luetkemeyer at IDWeek 2020

October 29, 2020